PRICE T ROWE ASSOCIATES INC /MD/
Position in CRL — Charles River Laboratories International, Inc.
CIK 80255
BALTIMORE, MD
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$194,087,167
+$179,553,853 QoQ
Shares Held
1,125,143
+1444.3% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.64099852196564.ToString("F0")%
Shared 0.ToString("F0")%
None 4.359001478034347.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,532,353,094 across 31 Diagnostics & Research names. CRL ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,315,471 | $3,104,243,460 | |
| 2 | DHR |
Danaher Corp /De/
|
15,352,887 | $2,910,907,374 | |
| 3 | NTRA |
Natera, Inc.
|
12,184,876 | $2,436,853,350 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,297,987 | $1,234,279,491 | |
| 5 | RVTY |
Revvity, Inc.
|
10,090,158 | $883,998,742 | |
| 6 | GH |
Guardant Health, Inc.
|
7,023,689 | $648,778,152 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
305,763 | $385,628,295 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
638,063 | $358,521,218 |
All Filings in CRL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,087,167 | 1,125,143 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,533,314 | 72,856 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,399,049 | 72,856 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,299,333 | 74,470 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,434,703 | 75,968 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,607,027 | 171,219 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,057,294 | 172,906 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $132,414,680 | 640,985 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $358,318,910 | 1,322,454 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $341,166,569 | 1,443,175 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $329,378,294 | 1,680,673 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $524,887,863 | 2,496,494 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $505,820,053 | 2,506,293 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $403,660,403 | 1,852,503 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $312,223,003 | 1,586,499 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $236,285,359 | 1,104,292 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $62,832,054 | 221,263 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $82,654,605 | 219,371 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $91,523,603 | 221,784 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $106,117,100 | 286,865 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $71,652,642 | 247,223 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $66,675,890 | 266,853 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $64,640,831 | 285,453 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $69,335,856 | 397,682 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $76,366,768 | 605,077 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||